Your browser doesn't support javascript.
loading
Cardiorenal Impact of Anti-Cancer Agents: The Intersection of Onco-Nephrology and Cardio-Oncology.
Attieh, Rose Mary; Nunez, Belen; Copeland-Halperin, Robert S; Jhaveri, Kenar D.
Afiliación
  • Attieh RM; Northwell Health, New York, New York, USA.
  • Nunez B; Division of Kidney Diseases and Hypertension, Glomerular Center at Northwell Health, Donald and Barbara Zucker School of Medicine at Hofstra/Northwell, Great Neck, New York, USA.
  • Copeland-Halperin RS; Northwell Health, New York, New York, USA.
  • Jhaveri KD; Division of Nephrology, Lenox Hill Hospital, Donald and Barbara Zucker School of Medicine at Hofstra/Northwell, New York, New York, USA.
Cardiorenal Med ; 14(1): 281-293, 2024.
Article en En | MEDLINE | ID: mdl-38684145
ABSTRACT

BACKGROUND:

The evolving landscape of cancer treatments has introduced new challenges, particularly related to adverse events associated with chemotherapeutic agents. To address these challenges, the fields of cardio-oncology and onco-nephrology have arisen, focusing on the management of cardiotoxicity and nephrotoxicity attributable to anti-cancer drugs.

SUMMARY:

Numerous intersections between these disciplines exist, including onco-hypertension (HTN) and cardiorenal toxicities induced by chemotherapeutic agents. Additionally, immune checkpoint inhibitors (ICIs) may cause myocarditis and nephritis. This paper aimed to explore the intersection between cardio-oncology and onco-nephrology. A detailed review will be undertaken, focusing on onco-HTN and the cardiorenal toxicities of chemotherapeutic agents, with a specific emphasis on the adverse effects associated with ICIs. KEY MESSAGES Multidisciplinary collaboration among oncologists, cardiologists, nephrologists, and other healthcare professionals is crucial for developing tailored approaches to optimize treatment efficacy while minimizing the risk of cardiovascular and renal complications, ultimately enhancing patient outcomes in modern oncology practice.
Asunto(s)
Palabras clave
Texto completo
Añadir a Mi BVS
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Cardiotoxicidad / Inhibidores de Puntos de Control Inmunológico / Oncología Médica / Neoplasias / Nefrología / Antineoplásicos Límite: Humans Idioma: En Revista: Cardiorenal Med Año: 2024 Tipo del documento: Article País de afiliación: Estados Unidos Pais de publicación: Suiza
Texto completo
Añadir a Mi BVS
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Cardiotoxicidad / Inhibidores de Puntos de Control Inmunológico / Oncología Médica / Neoplasias / Nefrología / Antineoplásicos Límite: Humans Idioma: En Revista: Cardiorenal Med Año: 2024 Tipo del documento: Article País de afiliación: Estados Unidos Pais de publicación: Suiza